Scientists hunt for clues to pre-eclampsia in placenta and blood samples

NCT ID NCT03626233

Recruiting now Knowledge-focused Sponsor: Centre Hospitalier Intercommunal Creteil Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study aims to better understand pre-eclampsia and intrauterine growth restriction (IUGR), serious pregnancy complications affecting about 9% of pregnancies. Researchers will collect placenta, blood, and urine samples from 500 pregnant women—both with and without these conditions—at delivery. By analyzing the genetics and proteins in these samples, they hope to uncover the underlying causes of these disorders, which currently have no cure and can worsen rapidly.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this research could uncover the biological causes of pre-eclampsia and IUGR, pointing toward future prevention or treatment strategies.
What could go wrong: This is an observational study collecting samples, not testing a treatment. It may not directly lead to new therapies, and results may take years to translate into clinical practice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INTRAUTERINE GROWTH RESTRICTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

fetal growth restriction preeclampsia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PRE-ECLAMPSIA

Contacts and locations

Locations

CHi Creteil
RECRUITING

Créteil, 94000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.